Date: June 27, 2016
Source: Indiana University
Summary: Many testicular cancer survivors experience hearing loss after cisplatin-based chemotherapy, according to researchers who studied, for the first time, the cumulative effects of cisplatin-based chemotherapy on hearing levels in testicular cancer survivors through comprehensive audiometry measurements. They found that increasing doses of cisplatin were associated with increased hearing loss at most of the tested frequencies, involving 4, 6, 8, 10, and 12 kHz.
Read more . . . Study Shows
University of Illinois
Sharon Parmet - Researchers at the University of Illinois at Chicago and Northwestern University are collaborating to develop a device to prevent hearing loss in patients undergoing chemotherapy.
Chemotherapy patients are often caught unaware when they find themselves dealing with hearing loss following treatment, according to David Klodd, professor of audiology in the UIC College of Medicine.
“Some commonly used chemotherapy drugs are ototoxic — that is, they can damage structures in the inner ear involved in hearing,” Klodd said.
Read more . . .